Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × decitabine and cedazuridine drug combination × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Myelodysplastic Syndromes 8 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 4 Myelodysplastic-Myeloproliferative Diseases 2 Anemia, Refractory, with Excess of Blasts 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neurofibrosarcoma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 GATA2 Deficiency 1 Carcinoma, Merkel Cell 1 BRCA1 Mutation 1 Allogeneic Stem Cell Transplantation 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

Dexamethasone 108 Lenalidomide 73 daratumumab 59 Bortezomib 49 pomalidomide 40 carfilzomib 39 Calcium Dobesilate 38 Cyclophosphamide 27 Specimen Handling 25 Biopsy 23 talquetamab 19 isatuximab 19 Magnetic Resonance Spectroscopy 19 fludarabine 17 iberdomide 15 dexamethasone acetate 14 dexamethasone 21-phosphate 14 belantamab mafodotin 14 auricularum 14 selinexor 13 elotuzumab 10 tocilizumab 9 fludarabine phosphate 8 trametinib 6 ixazomib 6 X-Rays 6 Melphalan 6 venetoclax 5 Whole-Body Irradiation 5 nirogacestat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡